Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

Reconciliations and other explanations of those non-GAAP financial measures can be found in today's press release and in the earnings supplement, each of which are available on the company's IR site.

Q1 2026 Earnings Call Transcript May 4, 2026Repay Holdings Corporation reports earnings inline with expectations.

AI capabilities are expanding broadly rather than concentrating narrowly. You have time for systematic experimentation, but ...

Speech therapy documentation isn’t just paperwork—it’s the foundation for effective treatment, legal compliance, and professional credibility. From structured note formats to HIPAA-compliant digital ...

Q2 2026 guidance assumes modest sequential improvement, though management notes that the pace of recovery in the Middle East ...

Grounded 2 receives a new update that brings various changes and improvements to the survival action-adventure experience for ...

Full-Year Guidance -- 2026 outlook reiterated, with management citing consistent performance and robust backlog as supporting factors. J.E. McAmis Acquisition -- Contribution characterized by new ...

Nader Emile and Hilal Itani, Partners at HKA in Saudi Arabia talk to MEC’s Jason Saundalkar about the evolving construction ...

An inmate said he discovered the note after Mr. Epstein was found injured in his jail cell, weeks before his death. It’s now ...

Stoy Hall, CFP and founder of Black Mammoth Wealth, shares how he approaches client emails. The secret is to treat every send like a conversation, not a broadcast.

A slow period doesn’t have to derail your business as a solo entrepreneur. Here’s how to rebound quickly and strategically.